Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Perner

Showing results (221-230 of 283) with videos related to

Pageof 29
Sort By:
Cancer Research|July 23, 2013
SOX2 expression associates with stem cell state in human ovarian carcinomaPetra M Bareiss, Anna Paczulla, Hui Wang, et al.
Neoplasia (New York, N.Y.)|August 4, 2009
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancerDorothee Pflueger, David S Rickman, Andrea Sboner, et al.
Urologic Oncology|December 5, 2017
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapyXin Chen, Christof Bernemann, Yuri Tolkach, et al.
Translational Oncology|April 17, 2026
CD3 and PD-L1 tissue expression have synergistic value in head and neck squamous cell carcinoma prognosisAdrian V Witzleben, Romain Remark, Christian Idel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United StatesJuan-Miguel Mosquera, Rohit Mehra, Meredith M Regan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate CancerJohannes Brägelmann, Niklas Klümper, Anne Offermann, et al.
Cancer Research|September 5, 2006
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancerSven Perner, Francesca Demichelis, Rameen Beroukhim, et al.
Familial Cancer|January 19, 2016
Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposisIsabel Spier, Martin Kerick, Dmitriy Drichel, et al.
Journal of Medical Genetics|November 29, 2015
Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis casesIsabel Spier, Dmitriy Drichel, Martin Kerick, et al.
The Journal of Molecular Diagnostics : JMD|December 26, 2012
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomyDimo Dietrich, Oliver Hasinger, Lionel L Bañez, et al.
Pageof 29

Showing results (221-230 of 283) with videos related to

Sort By:
Pageof 29
Cancer Research|July 23, 2013
SOX2 expression associates with stem cell state in human ovarian carcinomaPetra M Bareiss, Anna Paczulla, Hui Wang, et al.
Neoplasia (New York, N.Y.)|August 4, 2009
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancerDorothee Pflueger, David S Rickman, Andrea Sboner, et al.
Urologic Oncology|December 5, 2017
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapyXin Chen, Christof Bernemann, Yuri Tolkach, et al.
Translational Oncology|April 17, 2026
CD3 and PD-L1 tissue expression have synergistic value in head and neck squamous cell carcinoma prognosisAdrian V Witzleben, Romain Remark, Christian Idel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United StatesJuan-Miguel Mosquera, Rohit Mehra, Meredith M Regan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate CancerJohannes Brägelmann, Niklas Klümper, Anne Offermann, et al.
Cancer Research|September 5, 2006
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancerSven Perner, Francesca Demichelis, Rameen Beroukhim, et al.
Familial Cancer|January 19, 2016
Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposisIsabel Spier, Martin Kerick, Dmitriy Drichel, et al.
Journal of Medical Genetics|November 29, 2015
Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis casesIsabel Spier, Dmitriy Drichel, Martin Kerick, et al.
The Journal of Molecular Diagnostics : JMD|December 26, 2012
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomyDimo Dietrich, Oliver Hasinger, Lionel L Bañez, et al.
Pageof 29